Find clinical trials for Prostate Cancer in Paris, Île-de-France
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Paris, Île-de-France, FRA:
the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...
Levallois-Perret, France and 29 other locations
This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisi...
Phase 1, Phase 2
Villejuif, France and 12 other locations
to assess the preliminary signs of antitumor activity of darolutamide plus radiation therapy in patients with unfavorable intermediate risk prostate...
Phase 2
Paris, France and 9 other locations
primary trial objective is to demonstrate that ODM-201 produces prostate-specific antigen (PSA) response rates at 24 weeks (defined as ≥80% ...
Phase 2
Villejuif, France and 12 other locations
The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...
Phase 1, Phase 2
Villejuif, France and 50 other locations
with surgery in patients with high-risk and/or locally advanced prostate cancer.In this trial, patients will be assigned in one of ...
Phase 2
Paris, France and 19 other locations
and safety of darolutamide and of stereotactic dose escalated prostate radiotherapy in patients with localised prostate cancer...
Phase 3
Paris, France and 5 other locations
Prostate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men wo ...
Phase 1
Villejuif, Île-de-France Region, France and 24 other locations
This is a multicenter, randomized, open label, phase III study comparing the efficacy and safety of apatulamide combined with concomitant prostate...
Phase 3
Sarcelles, France and 14 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Paris, France and 296 other locations
Clinical trials
Research sites
Resources
Legal